• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Issachar Gil claimed ownership of 33,480 shares (SEC Form 3)

    3/19/25 6:30:52 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology
    Get the next $AIFF alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Issachar Gil

    (Last) (First) (Middle)
    C/O FIREFLY NEUROSCIENCE, INC.
    1100 MILITARY ROAD

    (Street)
    KENMORE NY 14217

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    08/12/2024
    3. Issuer Name and Ticker or Trading Symbol
    FIREFLY NEUROSCIENCE, INC. [ AIFF ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Technology Officer
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 33,480 D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Employee Stock Option (Right to Buy)(1) 08/13/2018 08/13/2023 Common Stock 13 $721.15 D
    Employee Stock Option (Right to Buy)(2) 10/14/2020 10/14/2025 Common Stock 222 $72.12 D
    Employee Stock Option (Right to Buy)(3) 04/01/2021 04/01/2026 Common Stock 77 $72.12 D
    Employee Stock Option (Right to Buy)(4) 06/21/2021 06/21/2026 Common Stock 1,308 $72.12 D
    Employee Stock Option (Right to Buy)(5) 11/17/2022 11/17/2027 Common Stock 2,920 $28.82 D
    Employee Stock Option (Right to Buy) (6) 07/08/2028 Common Stock 75,418 $5.18 D
    Explanation of Responses:
    1. Gil Issachar was granted an option to purchase 13 shares of common stock ("Option Shares") at an exercisable price of $721.15 per share on August 13, 2018.
    2. Gil Issachar was granted an option to purchase 222 shares of common stock ("Option Shares") at an exercisable price of $72.12 per share on October 14, 2020.
    3. Gil Issachar was granted an option to purchase 77 shares of common stock ("Option Shares") at an exercisable price of $72.12 per share on April 1, 2021.
    4. Gil Issachar was granted an option to purchase 1,308 shares of common stock ("Option Shares") at an exercisable price of $72.12 per share on June 21, 2021.
    5. Gil Issachar was granted an option to purchase 2,920 shares of common stock ("Option Shares") at an exercisable price of $28.82 per share on November 17, 2022.
    6. Gil Issachar was granted an option to purchase 75,418 shares of common stock ("Option Shares") subject a vesting schedule, in which the 75,418 Option Shares shall be vested in equal installment at the end of each calendar month for 36 months began on the date of grant on July 8, 2023.
    /s/ Gil Issachar 03/19/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AIFF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AIFF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AIFF
    Leadership Updates

    Live Leadership Updates

    See more
    • Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

      TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of current director of the Board, Greg Lipschitz, as Executive Chairman, effective as of December 3, 2024. "I look forward to taking on a more active leadership role as Executive Chairman," said Greg Lipschitz, newly appointed Executive Chairman of Firefly. "I believe that Firefly is uniquely positioned at the intersection of artificial intelligence and brain health that I have l

      12/4/24 9:00:00 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

      TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024. Dr. Vnook will serve as Chairperson of the Nominating Committee. Dr. Vnook brings over 25 years of experience as a distinguished pharmaceutical executive, serial entrepreneur, CEO and founder of multiple biotech companies and visionary leader with a track record of success in biotechnology and life

      9/5/24 9:00:00 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    Financials

    Live finance-specific insights

    See more
    • Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

      Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering wi

      11/14/24 5:30:18 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

      A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc., released on May 5, 2025 at 8:00 am ET. Please note, the correct form of payment of the potential Evoke investors' earn-out is in Firefly's common stock. The complete corrected press release follows: Builds upon Firefly's recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company")

      5/5/25 9:00:00 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

      Builds upon Firefly's recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announce its acquisition of Evoke Neuroscience, Inc. ("Evoke"), a medical device company developing and commercializing technologies to aid in the comprehensive assessment of brain health. The transaction marks another important step toward

      5/5/25 7:45:00 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

      KENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announced that it has received total proceeds of $8,824,710 from the exercise of warrants to purchase 823,530 shares of the common stock of the Company, par value $0.0001 per share ("common stock"), at an exercise price of $6.83, and warrants to purchase 800,000 shares of commons stock, at an exercise price of $4.00, respectively. The warrants were issued pursuant to private placements that closed

      2/21/25 8:00:00 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by CEO Lipschitz Gregory

      4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

      4/22/25 7:09:21 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 4 filed by President and COO Decaprio David

      4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

      4/22/25 7:08:38 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • New insider Issachar Gil claimed ownership of 33,480 shares (SEC Form 3)

      3 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

      3/19/25 6:30:52 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Firefly Neuroscience Inc.

      SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

      9/19/24 9:48:56 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G filed by Firefly Neuroscience Inc.

      SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

      8/21/24 6:07:51 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G filed by Firefly Neuroscience Inc.

      SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

      8/21/24 6:03:49 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    SEC Filings

    See more
    • SEC Form 10-Q filed by Firefly Neuroscience Inc.

      10-Q - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

      5/14/25 6:02:18 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

      5/5/25 6:20:09 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

      4/24/25 3:51:32 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology